SVB Leerink initiates coverage on Moderna (NASDAQ: MRNA) with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

New Coverage

Moderna (MRNA) Initiates Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)July 27, 2020 6:53 AM Moderna (MRNA) Reports $472M Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19July 27, 2020 5:51 AM